AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+27.87%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.4B
AUM Growth
+$2.4B
(+17%)
Cap. Flow
-$4.25M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
63.33%
Holding
107
New
9
Increased
18
Reduced
18
Closed
14
Top Buys
| 1 |
BioNTech
BNTX
|
$89M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$34.6M |
| 3 |
argenx
ARGX
|
$24.1M |
| 4 |
PayPal
PYPL
|
$21.6M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$18.5M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$70M |
| 2 |
NVIDIA
NVDA
|
$34.8M |
| 3 |
Avantor
AVTR
|
$22.7M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$17M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$16M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 27.76% |
| 3 | Communication Services | 1.58% |
| 4 | Technology | 1.29% |
| 5 | Financials | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $566M | 21.87% | 14,818,300 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $250M | 9.66% | 60,240,864 | – | – |
|
|
3
Alnylam Pharmaceuticals
ALNY
$58.5B
| $115M | 4.45% | 1,000,000 +300,000 | +43% | +$34.6M |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $106M | 4.1% | 640,000 -10,000 | -2% | -$1.66M |
|
5
Alibaba
BABA
$322B
| $95.4M | 3.69% | 450,000 | – | – |
|
6
Moderna
MRNA
$9.37B
| $90.1M | 3.48% | 4,606,298 | – | – |
|
|
7
BioNTech
BNTX
$24B
| $89M | 3.44% | +2,628,130 | New | +$89M |
|
|
8
Avantor
AVTR
$9.18B
| $86.2M | 3.33% | 4,750,000 -1,250,000 | -21% | -$22.7M |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $63.6M | 2.46% | 1,200,000 -300,000 | -20% | -$15.9M |
|
|
10
argenx
ARGX
$43.6B
| $56.2M | 2.17% | 350,000 +150,000 | +75% | +$24.1M |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $55.4M | 2.14% | 2,250,000 +750,000 | +50% | +$18.5M |
|
12
Fate Therapeutics
FATE
$120M
| $39.1M | 1.51% | 2,000,000 | – | – |
|
13
Zillow
Z
$20.4B
| $34.5M | 1.33% | 750,000 +100,000 | +15% | +$4.59M |
|
14
Scholar Rock
SRRK
$3.14B
| $33.6M | 1.3% | 2,546,040 +200,000 | +9% | +$2.64M |
|
|
BPMC
15
DELISTED
Blueprint Medicines
BPMC
| $32M | 1.24% | 400,000 -200,000 | -33% | -$16M |
|
|
MORF
16
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $31.2M | 1.21% | 1,819,186 | – | – |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $29.2M | 1.13% | 3,000,000 +500,000 | +20% | +$4.87M |
|
18
Atara Biotherapeutics
ATRA
$84.6M
| $28.8M | 1.11% | 1,750,000 +250,000 | +17% | +$4.12M |
|
19
Agios Pharmaceuticals
AGIO
$2.19B
| $28.7M | 1.11% | 600,000 +200,000 | +50% | +$9.55M |
|
|
RUBY
20
DELISTED
Rubius Therapeutics, Inc
RUBY
| $26.9M | 1.04% | 2,833,791 | – | – |
|
21
Gossamer Bio
GOSS
$562M
| $25.1M | 0.97% | 1,608,968 | – | – |
|
|
22
PayPal
PYPL
$67.1B
| $21.6M | 0.84% | +200,000 | New | +$21.6M |
|
23
Xencor
XNCR
$580M
| $18.9M | 0.73% | 550,000 +250,000 | +83% | +$8.6M |
|
|
TPTX
24
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $18.7M | 0.72% | 300,000 -100,000 | -25% | -$6.23M |
|
|
ARAV
25
DELISTED
Aravive, Inc. Common Stock
ARAV
| $18.5M | 0.71% | 1,350,000 +950,000 | +238% | +$13M |
|